FDA Approved: BIVALIRUDIN — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for Bivalirudin submitted by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction
• Unstable Angina

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

SUPPL AP for BIVALIRUDIN (BIVALIRUDIN)